vernodalin has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, A; Cheah, FK; Leong, KH; Looi, CY; Mohamad, K; Muharram, B; Mustafa, MR; Rai, N; Wong, WF | 1 |
| Ananda Sadagopan, SK; Arya, A; Hasanpourghadi, M; Karimian, H; Looi, CY; Mohebali, N; Mustafa, MR; Pandurangan, AK | 1 |
2 other study(ies) available for vernodalin and Breast Cancer
| Article | Year |
|---|---|
Induction of apoptosis in human breast cancer cells via caspase pathway by vernodalin isolated from Centratherum anthelminticum (L.) seeds.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Proliferation; DNA Fragmentation; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Plant Extracts; Reactive Oxygen Species; Seeds; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2013 |
Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Silencing; Humans; Intracellular Space; Phosphatidylinositol 3-Kinases; Plant Extracts; Protein Transport; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2015 |